Berlato et al. [37] detected abundant CCR4 expression in biopsy samples from advanced ccRCC patients and demonstrated that CCR4 antagonists remodeled the immune infiltration profile, resulting in reduced tumor weight in RCC-bearing mice. Here, CCR4 is linked to renal cell carcinoma.